Solange Oliveira Rodrigues Valle
Instituição:
Universidade Federal do Rio de Janeiro
Centro:
Hospital Universitário Clementino Fraga/CCS
Unidade:
Hospital Universitário Clementino Fraga/CCS
Departamento:
Divisão Médica DMD/HU
Formação:
-
Universidade Federal do Rio de Janeiro
Clínica Médica | Doutorado | 2009 - 2012
-
Universidade Federal do Rio de Janeiro
Clínica Médica | Mestrado | 1994 - 1998
-
Universidade Federal do Rio de Janeiro
Imunologia Clínica | Aperfeiçoamento | 1987 - 1988
-
Hospital Cardoso Fontes
| Especialização - Residência medica | 1985 - 1987
-
Fundação Técnico Educacional Souza Marques
Medicina | Graduação | 1979 - 1984
Laboratórios:
Nenhum laboratório cadastrado
Nuvens de Palavras:
Artigos:
(70.41% artigos com DOI)
| Titulo | DOI | Ano |
|---|---|---|
| Heat urticaria - Characterizing the population from an urticaria center of reference and excellence (UCARE) | 10.25259/ijsa_51_2023 | 2024 |
| Are pediatricians familiar with hereditary angioedema? | 10.1016/j.waojou.2023.100783 | 2023 |
| Hypertensive encephalopathy in hereditary angioedema: Concerns on bradykin in overflow | 10.52768/2766-7820/2361 | 2023 |
| Availability of genetic tests in public health services in Brasil: data from the brazilian rare diseases network | 2023 | |
| COVID-19 affecting hereditary angioedema patients with and without C1 inhibitor deficiency | 2023 | |
| Coexistência de doenças autoimunes: oportunidade para a associação de imunobiológicos? | 10.5935/2526-5393.20230027 | 2023 |
| O omalizumabe no tratamento da urticária no contexto da pandemia de COVID-19 | 10.5935/2526-5393.20230028 | 2023 |
| Urticaria exacerbations and adverse reactions in patients with chronic urticaria receiving COVID-19 vaccination: Results of the UCARE COVAC-CU study | 10.1016/j.jaci.2023.07.019 | 2023 |
| Biomarkers of chronic urticaria: what are their role? | 10.5935/2526-5393.20230037-en | 2023 |
| Risk factors for systemic reactions in typical cold urticaria: Results from the COLD-CE study | 10.1111/all.15194 | 2022 |
| Adrenaline autoinjector is underprescribed in typical cold urticaria patients | 10.1111/ALL15274 | 2022 |
| Chronic urticaria: profile from a reference center | 10.1016/j.abd.2021.01.006 | 2022 |
| Practical guide to urticaria for special patient groups | 10.5935/2526-5393.20220021 | 2022 |
| Practical guide to acute urticaria | 10.5935/2526-5393.20220022 | 2022 |
| Acquired Angioedema due to C1-Inhibitor Deficiency: A Challenging Condition | 10.1159/000521646 | 2022 |
| Pregnancy in Patients With Hereditary Angioedema and Normal C1 Inhibitor | 10.3389/falgy.2022.846968 | 2022 |
| Hereditary angioedema and Allergic bronchopulmonary aspergillosis: an unexpected association | 10.5935/2526-5393.20220015 | 2022 |
| 2022 Brazilian guidelines for hereditary angioedema - Part 1: definition, classification, and diagnosis | 10.5935/2526-5393.20220019 | 2022 |
| 2022 Brazilian guidelines for hereditary angioedema - Part 2: therapy | 10.5935/2526-5393.20220020 | 2022 |
| Validation and reproducibility of the International Study of Asthma and Allergies in Childhood (ISAAC) Written Atopic Eczema Questionnaire for telephone survey in children aged 6-7 years | 10.1016/j.abd.2021.03.010 | 2022 |
| Treatment patterns and outcomes in patients with chronic urticaria during pregnancy: Results of , a study | 10.1111/jdv.18574 | 2022 |
| Long-term Prophylaxis with Androgens in the management of Hereditary Angioedema (HAE) in emerging countries | 10.1186/s13023-022-02536-x | 2022 |
| Diretrizes brasileiras de angioedema hereditário 2022 - Parte 2: terapêutica | 10.5935/2526-5393-20220020 | 2022 |
| Epidemiology of rare diseases in Brazil: protocol of the Brazilian Rare Diseaes NetWork | 2022 | |
| Diretrizes brasileiras do angioedema hereditário 2022 - Parte 1: definição, classificação e diagnóstico | 2022 | |
| COVID-19 affecting hereditary angioedema patients with and without C1 inhibitor deficiency | 10.1016/j.jaip.2020.11.042 | 2021 |
| COVID-19 triggers attacks in HAE patients without worsening disease outcome | 10.1016/j.jaip.2021.12.008 | 2021 |
| Hereditary angioedema: how to approach it at the emergency department? | 10.31744/einstein_journal/2021rw5498 | 2021 |
| Hereditary angioedema: a disease seldom diagnosed by pediatricians | 10.1016/j.jped.2020.10.011 | 2021 |
| Spiritual well-being and quality of life are impaired in chronic urticaria | 10.23822/eurannaci.1764-1489.189 | 2021 |
| Chronic urticaria patients are interested in apps to monitor their disease activity and control: A UCARE CURICT analysis | 10.1002/clt2.12089 | 2021 |
| Urticária e a COVID-19 | 10.5935/2526-5393.20210021 | 2021 |
| TempTest®: Un instrumento de precisión en las urticarias físicas | 10.29262/ram.v68i1.827 | 2021 |
| Vacina COVID-19 em pacientes com urticária - Posicionamento do Departamento Científico de Urticária da Associação Brasileira de Alergia e Imunologia (ASBAI) | 10.5935/2526-5393.20210020 | 2021 |
| Effects of pregnancy on chronic urticaria: Results of the PREG-CU UCARE study | 10.1111/all.14950 | 2021 |
| The global impact of the COVID-19 pandemic on the management and course of chronic urticaria | 10.1111/all.14687 | 2021 |
| How are patients with chronic urticaria interested in using information and communication technologies to guide their healthcare? A UCARE study | 10.1016/j.waojou.2021.100542 | 2021 |
| Urticária e COVID-19: foco nesta manifestação clínica | 10.5935/2526-5393.20210016 | 2021 |
| The Challenges in the Follow-Up and Treatment of Brazilian Children with Hereditary Angioedema | 10.1159/000512944 | 2021 |
| The Panorama of Primary Angioedema in the Brazilian Population | 10.1016/j.jaip.2020.11.039 | 2021 |
| Angioedema hereditário: como abordar na emergência | 2021 | |
| Unnecessary Abdominal Surgeries in Attacks of Hereditary Angioedema with Normal C1 Inhibitor | 10.1007/s12016-021-08852-7 | 2021 |
| Validity, reliability, and interpretability of the Brazilian urticaria control test | 10.2500/aap.2020.41.200003 | 2020 |
| Efficacy of omalizumab in chronic spontaneous urticaria associated with chronic inducible urticaria | 10.1016/j.anai.2020.06.011 | 2020 |
| Hereditary angioedema: Report of the dental treatment of 12 Brazilian patients | 10.1016/j.oooo.2020.08.038 | 2020 |
| The usage, quality and relevance of information and communications technologies in patients with chronic urticaria: A UCARE study | 10.1016/j.waojou.2020.100475 | 2020 |
| Guia prático do tratamento com omalizumabe para urticária crônica espontânea | 10.5935/2526-5393.20200045 | 2020 |
| H1-Antihistamines May No Longer Be Necessary for Patients With Refractory Chronic Spontaneous Urticaria After Initiation of Omalizumab | 10.18176/jiaci.0464 | 2020 |
| Definition, aims, and implementation of GA 2 LEN/HAEi Angioedema Centers of Reference and Excellence | 10.1111/all.14293 | 2020 |
| Hereditary angioedema: a prospective study of a Brazilian single-center cohort | 10.1111/ijd.14676 | 2020 |
| Report on the use of Omalizumab in patients with Chronic Spontaneous Urticaria and COVID-19 | 10.5935/2526-5393.20200016 | 2020 |
| Urticárias crônicas induzidas: atualização do tema | 10.5935/2526-5393.20200047 | 2020 |
| Treatment of Patients with Hereditary Angioedema with Normal C1 Inhibitor: Evaluation of 295 Patients | 10.1016/j.jaci.2018.12.120 | 2019 |
| Hereditary angioedema: Screening of first-degree blood relatives and earlier diagnosis | 10.2500/aap.2019.40.4213 | 2019 |
| Guia prático da Associação Brasileira de Alergia e Imunologia para o diagnóstico e tratamento das urticárias baseado em diretrizes internacionais | 10.5935/2526-5393.20190052 | 2019 |
| Genotype-phenotype correlations in Brazilian patients with hereditary angioedema due to C1 inhibitor deficiency | 10.1111/all.13699 | 2019 |
| Hereditary Angioedema with Normal C1 Inhibitor and F12 Mutations in 42 Brazilian Families | 10.1016/j.jaip.2017.09.025 | 2018 |
| Omalizumab as add-on therapy in patients with asthma and allergic bronchopulmonary aspergillosis | 10.1590/s1806-37562017000000325 | 2018 |
| Ferramentas para avaliação e acompanhamento da urticária crônica | 10.5935/2526-5393.20180021 | 2018 |
| Avaliação do teste do soro autólogo e do teste do plasma autólogo na urticária crônica esponânea | 10.5935/2526-5393.20170039 | 2017 |
| ADAPTAÇÃO TRANSCULTURAL DO QUESTIONÁRIO "URTICARIA CONTROL TEST" PARA O PORTUGUÊS BRASILEIRO | 10.6020/1679-9844/v12n4a9 | 2017 |
| Diretrizes brasileiras para o diagnóstico e tratamento do angioedema hereditário - 2017 | 10.5935/2526-5393.20170005 | 2017 |
| Genotype-Phenotype Correlations in Patients with Hereditary Angioedema | 10.1016/j.jaci.2016.12.921 | 2017 |
| Impact of chronic urticaria on the quality of life of patients followed up at a university hospital | 10.1590/abd1806-4841.20165071 | 2016 |
| Cross-cultural adaptation and validation of health questionnaires | 10.5935/2318-5015.20160003 | 2016 |
| Coagulation factor XII gene mutation in Brazilian families with hereditary angioedema with normal C1 inhibitor | 2015 | |
| Coagulation Factor XII Gene Mutation in Brazilian Families with Hereditary Angioedema with Normal C1 Inhibitor | 10.1159/000376547 | 2015 |
| Analysis of the prevalence of subtypes of angioedema without urticaria in a reference center in Rio de Janeiro - Brazil | 10.1186/1939-4551-8-S1-A39 | 2015 |
| Icatibant, an inhibitor of bradykinin receptor 2, for hereditary angioedema attacks: prospective experimental single-cohort study | 2014 | |
| Hereditary angioedema: quality of life in Brazilian patients | 10.6061/clinics/2013(01)oa13 | 2013 |
| Atopy patch test with aeroallergens: a promising tool in the diagnosis of atopic dermatitis | 10.5935/2318-5015.20130011 | 2013 |
| Anti-IgE in chronic urticaria | 10.5935/2318-5015.20130026 | 2013 |
| Hereditary angioedema: first report of the Brazilian registry and challenges | 2012 | |
| Validity and Reproducibility of the Asthma Core International Study of Asthma and Allergies in Childhood (ISAAC) Written Questionnaire Obtained by Telephone Survey | 10.3109/02770903.2012.669440 | 2012 |
| Atopy patch test (APT) in the diagnosis of food allergy in children with atopic dermatitis | 10.1590/S0365-05962012000500009 | 2012 |
| Prevalence of autoantibodies in a group of hereditary angioedema patients | 10.1590/s0365-05962012000200030 | 2012 |
| C1 estearase inhibitor for the treatment of acute hereditary angioedema. | 2011 | |
| Cross-cultural adaptation of the Brazilian-Portuguese version of the chronic urticaria quality-of-life questionnaire - CU-Q2oL | 10.1111/j.1398-9995.2011.02695.x | 2011 |
| Dapsone hypersensitivity syndrome during delayed pressure urticaria treatment | 2010 | |
| Hereditary Angioedema and Chronic Urticaria: Is there a Possible Association? | 2009 | |
| Urticária de pressão tardia com manifestações sistêmicas: relato de caso | 2009 | |
| Teste do soro autólogo na urticária crônica | 2009 | |
| Delayed pressure urticaria with systemic manifestations: Case report | 2009 | |
| Hereditary angioedema (HAE) in Brazil: Registry of 120 cases | 2007 | |
| Angioedema hereditário com inibidor de C1 normal - relato de caso e revisão da literatura | 2007 | |
| Influências do sistema neuro-imuno-endócrino | 2007 | |
| Urticária de pressão tardia | 2007 | |
| Asma e síndrome de Churg-Strauss | 2006 | |
| Guia prático para o manejo da dermatite atópica - opinião conjunta de especialistas em alergologia da associação brasileira de alergia e imunopatologia e da sociedade brasileira de pediatria | 2006 | |
| Angioedema hereditário: intervenções iatrogênicas - Caso clínico comentado | 2005 | |
| Pesquisa de fungos em 20 pacientes com polipose nasossinusal | 2002 | |
| Sinusite fúngica alérgica: atualizaçäo | 1998 | |
| Asma e sinusite: importância da associaçäo e principais mecanismos patogênicos | 1995 | |
| Urticária de pressao tardia. Relato de um caso | 1993 | |
| Vascularite urticriforme. Manifestações precoce do lúpus eritematoso sistêmico. Relato de três casos | 1993 | |
| Reactivity to purified protein derivative and the risk of tuberculosis in HIV-infected brazilian patients | 1993 | |
| Choque anafilático. Conduta terapêutica e atualizaçäo | 1992 | |
| Síndrome de Melkersson-Rosenthal: relato de um caso clínico | 1990 |
Eventos:
(0.00% eventos com DOI)